Showing 271-280 of 1457 results for "".
Vaseline Radiant X Even Tone Nourishing Body Lotion
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/vaseline-radiant-x-even-tone-nourishing-body-lotion/24004/The Best Skincare Products for Eczema, According to Your Peers
https://practicaldermatology.com/topics/atopic-dermatitis/the-best-skincare-products-for-eczema-according-to-your-peers/23747/Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-2/23034/Game On: Learning Gets Upgraded
https://practicaldermatology.com/topics/practice-management/game-on-learning-gets-upgraded/23544/Will gamification change the way dermatologists learn?Charging Toward Stage 2 of Meaningful Use
https://practicaldermatology.com/topics/practice-management/charging-toward-stage-2-of-meaningful-use/21467/As the next stage of the Federal EHR incentive program is set to begin, the forecast remains uncertain.Bristol-Myers Squibb Acquires Celgene, My UV Tracker, More
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-bristol-myers-squibb-acquires-celgene-my-skin-track-uv-more/19534/Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 Billion. Suneva® Medical partners with Healeon Medical, Inc. and Puregraft, LLC to add two new products to its aesthetics portfolio. Unveiled at the 2018 Consumer Electronics Show, theOwner Succession Planning
https://practicaldermatology.com/topics/practice-management/owner-succession-planning/23692/Exploring business owner succession is important no matter where you are in your business’s life-cycle.It's Complicated
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-complicated/20627/One surgeon discusses why you should embrace complications.Optimizing Acne Treatment: The Importance of the First Follow-up
https://practicaldermatology.com/topics/general-topics/optimizing-acne-treatment-the-importance-of-the-first-follow-up/20972/The first follow-up visit is a time to measure efficacy and compliance, reinforce key messages, make adjustments to the regimen, and discuss acne sequela.Biosimilars: What's Coming for Labeling?
https://practicaldermatology.com/topics/practice-management/biosimilars-whats-coming-for-labeling/20934/The public comment period on draft labeling guidance will end next month.